St. Mary’s signed a letter of intent with Ontario, Calif.-based Prime in November 2012 that at the time listed the purchase price at $25 million, though the actual agreed-upon price has not been disclosed, according to a report by The Record.
Terms of the agreement stipulate that St. Mary’s, the only hospital remaining in its area after two others closed, must remain an acute-care hospital for at least five ears.
Prime, which operates 21 other acute-care hospitals across the country, will maintain a local governing board, but it must follow St. Mary’s charity and ethical care policies, honor the existing collective bargaining agreement for unionized employees and invest $30 million in capital improvements during the five-year period.
More Articles on Hospital Transactions:
UHS VP of Development Richard Wright Resigns
2 Major Brooklyn Hospitals Begin Exploratory Affiliation Talks
SCL Health System Sells 2 Kansas Hospitals to Prime Healthcare
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
